News

Filter

Current filters:

None

7900 to 7909 of 95871 results

Spectrum upbeat on lymphoma drug Zevalin study

24-01-2012

US biotech firm Spectrum Pharmaceuticals (NasdaqGS: SPPI) yesterday announced results of a randomized…

BiotechnologyOncologyResearchSpectrum PharmaceuticalsZevalin

Novo Nordisk opens type 1 diabetes R&D center in Seattle

24-01-2012

Danish insulin giant Novo Nordisk (NVO: N) said this morning that it will establish a type 1 diabetes…

DiabetesNovo NordiskPharmaceuticalResearch

FDA lifts hold on Insmed Arikace trial

23-01-2012

USA-based biopharma company Insmed’s (Nasdaq CM: INSM) shares leapt 33.7% to $5.08 on Friday, after…

ArikaceBiotechnologyInsmedNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

ShangPharma milestone in Hengrui accord; expands Lilly contract

23-01-2012

Leading Chinese R&D outsourcing firm ShangPharma Corp (NYSE: SHP) says that it has reached the first…

Asia-PacificEli LillyJiangsu Hengrui MedicinePharmaceuticalResearchShangPharma

Significant advances in biosimilar medicines claimed for Iran

23-01-2012

Iran is making significant advances in medicine production, especially in the fields of biosimilar and…

BiotechnologyGenericsMarkets & MarketingRest of the World

Pharma industry could use a shot in the arm, says Fitch; FT views bribery settlements

23-01-2012

2012 will be a critical year for the pharmaceutical industry, as drugmakers struggle with record patent…

FinancialLegalMarkets & MarketingPatentsPharmaceuticalResearch

Thyroid cancer risk discovery by deCODE Genetics and collaborators

23-01-2012

Scientists at Iceland-based human genome specialist deCODE Genetics and academic collaborators from Iceland,…

BiotechnologydeCODE GeneticsOncologyResearch

EMA starts review of Gilenya; guidance on biosimilar interferon beta

23-01-2012

The European Medicines Agency has begun a review of the benefits and risks of Swiss drug major Novartis’…

BiotechnologyEuropeGenericsGilenyainterferon betaNeurologicalNovartisPharmaceuticalRegulation

FDA updates Tysabri label relating to anti-JCV

23-01-2012

The US Food and Drug Administration on Friday approved a product label change for Tysabri (natalizumab),…

Biogen IdecBiotechnologyElanNeurologicalNorth AmericaPharmaceuticalRegulationTysabri

7900 to 7909 of 95871 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top